Valin Technologies

Company Overview

Snapshot

Founded in January 2010 by Marian Gorecki, PhD, Saul Mashaal, and Yehuda Zelig, Valin Technologies operates with 11–50 employees. The company focuses on the research and development of biological therapeutics and biosimilars, with a notable technology success story in January 2017 regarding directed evolution in the treatment of psoriasis.

Business overview

Valin Technologies is a biotechnology company specializing in the research and development of biological therapeutics and biosimilars. The company's core competency spans the entire biopharmaceutical development value chain, from early discovery and process development to CMC, preclinical, and clinical development, through to regulatory approval. Valin Technologies develops drugs for markets with unmet needs and high business potential, operating R&D laboratories in Yavne and Israel, alongside a GMP mini-pilot plant and two biologic manufacturing facilities in China. The company primarily serves the pharmaceuticals market within the broader healthcare and life sciences industries.

Company Intelligence Q&A

What is Valin Technologies' primary focus?

Valin Technologies is a biotechnology company focused on the research and development of biological therapeutics and biosimilars, developing drugs for markets with unmet needs and high business potential.

When was Valin Technologies founded and by whom?

Valin Technologies was founded in January 2010 by Marian Gorecki, PhD, Saul Mashaal, and Yehuda Zelig.

Where does Valin Technologies conduct its research and manufacturing?

Valin Technologies manages R&D laboratories in Yavne, Israel, and China, and operates a GMP mini-pilot plant and two biologic manufacturing facilities in China.

What is a key technology success story for Valin Technologies?

In January 2017, Valin Technologies achieved a technology success in directed evolution for the treatment of psoriasis, highlighting its expertise in pharmaceuticals, biotechnology, and autoimmune diseases.

What is the current product stage of Valin Technologies' offerings?

Valin Technologies' products are currently in the Clinical Trial stage, indicating they are undergoing human testing to evaluate their safety and efficacy before potential regulatory approval.